Your browser doesn't support javascript.
loading
Therapeutic Drug Monitoring of Long-Acting Injectable Antipsychotic Drugs.
Schoretsanitis, Georgios; Baumann, Pierre; Conca, Andreas; Dietmaier, Otto; Giupponi, Giancarlo; Gründer, Gerhard; Hahn, Martina; Hart, Xenia; Havemann-Reinecke, Ursula; Hefner, Gudrun; Kuzin, Maxim; Mössner, Rainald; Piacentino, Daria; Steimer, Werner; Zernig, Gerald; Hiemke, Christoph.
Afiliación
  • Schoretsanitis G; The Zucker Hillside Hospital, Psychiatry Research, Northwell Health, Glen Oaks, NY.
  • Baumann P; Department of Psychiatry, University of Lausanne, Prilly-Lausanne, Switzerland.
  • Conca A; Department of Psychiatry, Central Hospital, Sanitary Agency of South Tyrol, Bolzano, Italy.
  • Dietmaier O; Psychiatric Hospital, Klinikum am Weissenhof, Weinsberg, Germany.
  • Giupponi G; Department of Psychiatry, Central Hospital, Sanitary Agency of South Tyrol, Bolzano, Italy.
  • Gründer G; Department of Molecular Neuroimaging, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Hahn M; Department of Psychiatry and Psychotherapy, University of Frankfurt, Frankfurt, Germany.
  • Hart X; Department of Molecular Neuroimaging, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Havemann-Reinecke U; Department of Psychiatry and Psychosomatics, University of Göttingen, Göttingen, Germany.
  • Hefner G; Forensic Psychiatric Hospital, Vitos Klinik, Eichberg, Eltville, Germany.
  • Kuzin M; Psychiatric and Psychotherapeutic Private Clinic Clienia Schlössli, Academic Teaching Hospital of the University of Zurich, Oetwil am See, Switzerland.
  • Mössner R; Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany.
  • Piacentino D; Department of Psychiatry, Central Hospital, Sanitary Agency of South Tyrol, Bolzano, Italy.
  • Steimer W; Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, National Institute on Drug Abuse Intramural Research Program, National Institute on Alcohol Abuse and Alcoholism, Division of Intramural Clinical and Biological Research, National Institutes of Health, Bethesda, MD.
  • Zernig G; Institute of Clinical Chemistry and Pathobiochemistry, Technical University Munich, Munich, Germany.
  • Hiemke C; Department of Psychiatry, Medical University of Innsbruck, Innsbruck, Austria.
Ther Drug Monit ; 43(1): 79-102, 2021 02 01.
Article en En | MEDLINE | ID: mdl-33196621
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esquizofrenia / Antipsicóticos / Monitoreo de Drogas Límite: Humans Idioma: En Revista: Ther Drug Monit Año: 2021 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esquizofrenia / Antipsicóticos / Monitoreo de Drogas Límite: Humans Idioma: En Revista: Ther Drug Monit Año: 2021 Tipo del documento: Article